– USA, TN – Petauri Health, a purpose-built pharmaceutical services platform, today announced the elections of Dr. William Fleming (PharmD) and Jim Robinson to its Board of Directors.
About Dr. William Fleming
With a nearly 30-year track record at Humana, Dr. Fleming is passionate about simplifying healthcare, providing value to consumers, and fostering high-performing teams. Currently the company’s Chief Corporate Affairs Officer, William develops and strengthens relationships with government partners to impact public health policy. He also oversees the company’s Humana Military members, along with Humana’s Medicare Prescription Drug Plans (PDPs). During his tenure at Humana, William has led various divisions, focusing on clinical integration and improving health outcomes. As a member of Humana’s Management Team, he reports to the President and CEO, contributing to Humana’s mission of enhancing healthcare and clinical quality.
William received his BS in Pharmacy from the University of Kentucky College of Pharmacy, where he went on to receive his Doctor of Pharmacy. He also holds a BA in General Studies from Transylvania University, with an emphasis in biology and economics. William has held numerous prior board/trustee appointments with various pharmacy and charity organizations. Recognizing his commitment to further developing the industry, William was named a Fellow in the Academy of Managed Care Pharmacy.
About James Robinson
Over his 30-year career in the healthcare industry, Jim has experienced nearly every aspect of the field, to which he brings a relentless drive to make a meaningful impact on the lives of patients and their families suffering from some of the most devastating medical conditions, including cancer and urological disease. The 2023 recipient of PM360’s Trailblazer Award for CEO of the Year (Life Sciences Manufacturer), James is an advisor to BridgeBio, a board member of Eledon Pharmaceuticals and of UroGen Pharma, and was most recently CEO and a board member of Urovant Sciences.
Before his work with Urovant Sciences, James held executive leadership positions at Paragon Biosciences, Alkermes, and Astellas. He began his career, in 1992, at Schering-Plough after receiving his BS in Marketing from DePaul University.
About Petauri Health
Petauri is a purpose-built pharmaceutical services platform based in Nashville, Tenn. Founded by Dan Renick in partnership with Oak Hill Capital, the platform recently acquired The Kinetix Group and seeks to actively acquire and combine additional best-in-class companies with recognized expertise in global market access, medical affairs, patient services, and data and analytics. Over time, Oak Hill aims to invest more than $250 million of equity capital in this initiative from its latest fund (OHCP VI). The resulting platform will work with pharmaceutical and life sciences clients, to improve patient outcomes by establishing the scientific, economic, humanistic, and societal value of medical advances, and seamlessly support these clients with data-driven, digital-forward solutions that speed patient access to life-changing care.
For more information: https://petaurihealth.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.